Breaking News, Promotions & Moves

Corbus Announces Key Hires

Dr. Robert Discordia will serve as VP, Pharmaceutical Development & Mfg, and Ross Lobell will serve as VP, Regulatory Affairs

Corbus Pharmaceuticals Holdings has appointed Robert Discordia, Ph.D., as vice president, Pharmaceutical Development & Manufacturing, and Ross Lobell as vice president, Regulatory Affairs. Dr. Discordia will oversee all aspects of Corbus’ chemistry, manufacturing and controls (CMC) for lenabasum and future drug candidates. Mr. Lobell will lead Corbus’ Regulatory Affairs and Quality Assurance groups. “We are delighted to welcome Robert and Ross to the Corbus team.  We look forward to t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters